Study Reveals Distinct Breast Cancer Biology in Native Women

A pioneering study has uncovered significant biological differences in breast cancer among Native women, suggesting current treatments might not be universally effective. While Native women are diagnosed with breast cancer less frequently than other demographics, they tragically face higher mortality rates from the disease. This disparity persists despite a general decline in breast cancer deaths over the past three decades. Researchers at the University of Notre Dame analyzed breast cancer tissue from Native women, comparing it to a larger cohort of white women. They identified distinct genetic mutations and unique ways tumors evade the body's immune system.

These findings are critical because, historically, breast cancer research and genomic databases have largely overlooked Native American populations. The study indicates that the biological mechanisms driving cancer in Native women may differ from those in white women, who have predominantly been the focus of research. Understanding these molecular-level differences is crucial, complementing the known impact of social determinants of health, to better address health disparities and improve outcomes for Native communities. The Harper Cancer Research Institute plans further studies on other cancers affecting these communities.